Retaglutide is a novel GLP-1 receptor agonist currently under research for the treatment of metabolic disorders. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://sashaiesm927771.blog-mall.com/39679345/trelaglutide-exploring-a-new-option-for-chronic-diseases